INTRODUCTION
============

The eukaryotic genome is assembled with histones into a highly ordered chromatin structure. The basic unit of chromatin is the nucleosome, which consists of 146 bp of DNA wrapped around the histone octamer ([@B1]). Histones are subjected to various post-translational modifications (PTM), including phosphorylation, acetylation, ubiquitination and methylation ([@B2],[@B3]). These covalent modifications alter chromatin dynamics to regulate DNA processes ([@B4],[@B5]).

For a long time, histone lysine methylation was considered to be irreversible until the identification of the first histone demethylase, lysine-specific demethylase 1 (LSD1) ([@B6]). However, the LSD1/KDM1 (lysine demethylase) type of histone demethylase can only demethylate mono- and di-methylated lysine because of its catalytic characteristics. A distinct family of histone demethylases containing Jumonji C (JmjC) domains (JHDMs) is highly conserved from budding yeast to humans. The catalytic JmjC domain is required for oxidative demethylation; it requires Fe (II) and α-ketoglutarate as cofactors and can demethylate mono-, di- and tri-methylated substrates ([@B7],[@B8]).

Dozens of JHDMs have been discovered to have various functions in regulation of gene expression, cell growth and development ([@B9],[@B10]). The role of JHDMs in transcriptional regulation has been reported in mammals. Mammalian JHDM1 and JHDM2 subfamilies reverse mono- and di-methylated H3K36 and H3K9, respectively, and the JHDM3 subfamily preferentially antagonizes di- and tri-methylation of H3K36 and H3K9 ([@B8],[@B11],[@B12]). JHDM2A acts on mono-/di-methyl H3K9 and plays important roles in nuclear hormone receptor-mediated gene activation, male germ-cell development, obesity control and metabolic gene expression ([@B12; @B13; @B14]). JHDM3A, the tri-methyl-specific demethylase for H3K36 and H3K9, negatively regulates *ASCL2* transcription ([@B11]).

Previously, we characterized four JmjC-containing proteins (Rph1, Jhd1, Gis1 and Jhd2) in the budding yeast *Saccharomyces cerevisiae* and demonstrated that Rph1, Jhd1 and Gis1 are specific to H3K36, whereas Jhd2 is H3K4 specific ([@B15]). Notably, Rph1 is the only demethylase targeting H3K36 tri-methylation; Jhd1 and Gis1 specifically demethylate mono-/di-methylated H3K36. In general, histone methylation on H3K36 is thought to be involved in transcriptional elongation ([@B16]). In *S. cerevisiae*, H3K36 is methylated by the histone methyltransferase Set2 ([@B17]). Set2 interacts with the phosphorylated C-terminal domain of RNA polymerase II to methylate H3K36 during transcriptional elongation within the body of actively transcribed genes ([@B18]). This methylation is recognized by Eaf3, a subunit of the small Rpd3 (Rpd3S) histone deacetylase complex (HDAC). The recruitment of HDAC further removes the acetyl group from hyper-acetylated histones of transcribed genes to re-build a compact chromatin structure. During transcriptional elongation, H3K36 methylation prevents aberrant intragenic transcription ([@B19]). Recently, two JmjC-domain-containing proteins, Rph1 and Jhd1, were shown to bypass the lethality of deletion of *BUR1*, a cyclin-dependent kinase of RNA polymerase II. Therefore, the demethylase activity toward H3K36 methylation could be related to transcriptional elongation ([@B20]). In addition, H3K36 methylation was reported to be involved in regulating the transcriptional initiation at the *MET16* promoter region ([@B21]). Even though H3K36 methylation is known to be involved in the regulation of transcription, the detailed functions of reversible H3K36 demethylation remain unclear.

The H3K36 demethylase Rph1, also known as KDM4 ([@B22]), was originally defined as a repressor of the *PHR1* gene ([@B23]). *PHR1* encodes the apoenzyme for the DNA repair enzyme photolyase, which catalyzes the repair of pyrimidine dimers in the presence of visible light ([@B24; @B25; @B26; @B27]). Previous *in vitro* footprinting studies showed that Rph1 represses the expression of *PHR1* by associating with the upstream repression sequence (URS) of the *PHR1* promoter ([@B23]). Although Rph1 is now known to be a histone demethylase, whether its H3K36 demethylase activity plays a role in the transcriptional regulation of *PHR1* remains to be elucidated.

Here, we investigated the role of Rph1 in repressing the transcription of *PHR1* in a histone demethylase-dependent manner. We revealed Rph1 associated with the URS region of the *PHR1* promoter via its zinc-finger (ZF) domains and was dissociated after UV irradiation. Rph1-mediated histone demethylation influenced the dynamic crosstalk between histone methylation and acetylation with Rpd3 at the URS region of *PHR1* promoter. Furthermore, we revealed that Rad53 functions as an upstream activator of *PHR1* by phosphorylation of Rph1 in a Rad53 kinase-dependent manner. Phosphorylation at S652 of Rph1 potentially contributes to its dissociation from chromatin and modulates the transcriptional de-repression of *PHR1* in response to DNA damage. Our study demonstrates that the H3K36 demethylase Rph1 regulates *PHR1* expression by association with the promoter and by altering chromatin modifications under the control of DNA damage checkpoint signaling.

MATERIALS AND METHODS
=====================

Plasmids and yeast strains
--------------------------

All recombinant plasmids were constructed by use of the Gateway system \[([@B28]), Invitrogen\]. The coding region of *RPH1* was synthesized by PCR and recombined to the pDONR2.1 to generate BP-*RPH1*. The mutants of Rph1, including the catalytic-deficient mutant H235A ([@B15]), phosphorylation sites and ZF deletion mutants were generated by site-directed mutagenesis and verified by DNA sequencing. For inducible expression of Rph1, BP-*RPH1* was cloned into the BG1805 vector (Open Biosystems) by the Gateway system ([@B29]). For constitutive expression of Rph1 in yeast, we first generated a set of yeast destination vectors by modification of pRS vectors (pRS415 and pRS425) with a *GPD1* promoter or a *RPH1* promoter (800 bp upstream of ATG), a *CYC1* terminator and the chloramphenicol/ccdB cassette for recombinational cloning. The pET21 vector (Merck) was used for expression of recombinant proteins in the bacterial system. All recombinant plasmids identified from individual *Escherichia coli* colonies were verified by sequencing. The yeast strains used in this study are described in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1). *Saccharomyces cerevisiae* BY4742 and BY4743 were used as the wild-type (WT) yeast strain. Homozygous knockout strains of *RPH1* in the BY4742 or BY4743 background were obtained from the Saccharomyces Genome Deletion Project ([@B30]).

UV irradiation treatment
------------------------

Yeast cultures were grown in synthetic-complete selection medium until the A~600~ reached 0.6--0.8, then transferred to YP medium containing 2% galactose at 30°C to induce gene expression. After 4 h induction, cell pellets were collected and spread on YP galactose (YPGal) plates. The plates were UV irradiated (Stratalinker, Stratagene) with the indicated doses (0--30 mJ/cm^2^). After 30 min of recovery, the cells were harvested for further analysis. The procedure for UV-sensitivity testing was as described ([@B15]). The induced cells were spotted on the indicated plates by serial dilutions. After UV irradiation, plates were grown for 2--3 days at 30°C before data collection.

Reverse transcription
---------------------

Total RNA was extracted from yeast cells by use of a total RNA mini kit (Geneaid). RNA (1 μg) was treated with DNAse I (Promega) followed by reverse transcription with use of Moloney Murine Leukemia Virus High Performance Reverse Transcriptase (MMLV HP RT) (Epicentre) and oligo-dT primer (Protech) according to the manufacturer's instructions. Reverse transcription of RNA samples from each biological experiment was performed and the resulting cDNA was used for PCR analysis.

Real-time quantitative PCR
--------------------------

Real-time quantitative PCR (qPCR) with SYBR green detection was performed as described ([@B31]) by use of an ABI Prism 7000 thermocycler with fluorescence detection (Applied Biosystems). All primers used are indicated in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1). Appropriate non-template controls were included in each PCR reaction, and dissociation analysis was performed at the end of each run to confirm the specificity of the reaction.

Chromatin immunoprecipitation assay
-----------------------------------

Chromatin immunoprecipitation (ChIP) was performed as described ([@B32],[@B33]). To maintain proper size of fragmented chromatin, we optimized the sonication and sheared DNA with an average size of 100--200 bp ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)) corresponding to 1 or 2 nucleosomes. For Rpd3 ChIP, samples were fixed with dimethyl adipimidate (Sigma) and formaldehyde ([@B34]). of chromatin solution (0.75--1 mg) was immunoprecipitated (IP) with indicated antibodies \[HA-tag/Myc-tag (Roche), H3K36me3 (Abcam), acetylated histone H3(K9/14)/H4(K5/8/12/16) (Upstate) and Rpb3 (Neoclone)\] and purified with protein A or G sepharose (Upstate). The precipitated DNA was analyzed by semi-quantitative PCR or real-time qPCR. For semi-quantification, PCR products were separated by electrophoresis and followed by quantification (Image Quant software, GE). Real-time qPCR analysis was performed as described above. For each ChIP, the signal for each gene primer pair in the immunoprecipitation was normalized to that of the input and then divided by the control vector to determine the fold change. Quantification of data was based on the number of independent biological and experimental replicates indicated in each figure.

*In vitro* kinase assay
-----------------------

Rad53 kinase assay was performed as described ([@B35],[@B36]). Briefly, yeast carrying WT or kinase-dead Rad53 fused with V5 and 6 copies of His tags was treated with 0.05% MMS for 1 h, and total proteins were extracted for immunoprecipitation with anti-V5 antibody. Protein G-bound Rad53 was incubated with 1 μg recombinant Rph1 or BSA (New England Biolabs) and 5 μCi of γ^32^P-ATP (3000 Ci/mmol, PerkinElmer) in 20 μl kinase buffer (40 mM Hepes-NaOH pH 8.0, 1 mM DTT, 20 mM MgCl~2~, 20 mM MnCl~2~, 100 μM sodium orthovanadate and 0.02 mM ATP) at 30°C for 30 min. The reaction was stopped by addition of SDS-loading buffer and followed by SDS--PAGE electrophoresis. The autoradiography signal was captured and quantitated by phospho-imager (Typhoon 9200 Scanner, GE Healthcare).

Statistical analysis
--------------------

Comparison of 2 groups involved Student's *t*-test. A *P* \< 0.05 was considered statistically significant. A regression procedure was used to explore the correlation between the experimental condition and *PHR1* expression and to identify potentially important predictors. Statistical analyses involved use of Microsoft Excel and SPSS (SPSS Inc., Chicago, IL, USA) ([@B37]).

RESULTS
=======

The H3K36 demethylase Rph1 regulates *PHR1* transcription
---------------------------------------------------------

To characterize the biological function of histone demethylases, including Rph1, Jhd1 and Jhd2, we first performed phenotypic analyses and observed that deletion of any histone demethylase caused no overt growth phenotype ([@B15]), which may be due to overlapping activities of the multiple histone lysine demethylases in yeast. In an independent approach, we used overexpression to probe the function of individual histone demethylases. Of these, only Rph1 overexpression showed elevated sensitivity to UV-induced damage ([@B15]). However, the constitutive overexpression of Rph1 with its own promoter in a multi-copy (2μ) plasmid caused a severe defect in cell growth ([Figure 1](#F1){ref-type="fig"}A, left panel and 2 lower rows in right panel). Thus, we used an inducible expression strategy to study the biological phenotype resulting from temporally increased Rph1 levels. Cells with galactose-inducible overexpression of *RPH1* grew well without UV treatment yet displayed hypersensitivity to UV irradiation at 25 mj/cm^2^ ([Figure 1](#F1){ref-type="fig"}A, 2 upper rows in right panel). Because previous experiments suggested that Rph1 is a histone demethylase specific to tri-methylated-H3K36 ([@B15],[@B38]), we surmised that the demethylation at H3K36 may be linked to UV sensitivity. To test the possibility, we used alanine-substituted mutants blocking methylation at histone H3 K4, K36 and K79 in UV-sensitivity assays. Interestingly, only histone H3K36A and H3K79A mutants showed increased UV sensitivity ([Figure 1](#F1){ref-type="fig"}B, upper panel). Dot1-mediated H3K79 methylation is linked with H2B ubiquitination and is involved in the DNA damage response ([@B39]). However, H3K36 methylation in the UV damage response has not been well-established. Furthermore, we found that the deletion of the H3K36 methyl-transferase Set2 (*set2Δ*) also enhanced the UV sensitivity ([Figure 1](#F1){ref-type="fig"}B, middle panel). Moreover, overexpression of Rph1 in the WT conferred high sensitivity to UV irradiation, whereas overexpression of Rph1 combined with *set2Δ* caused an additive effect ([Figure 1](#F1){ref-type="fig"}B, lower panel), which was more significant at a higher dosage. These observations suggest that Set2 and Rph1 likely work in parallel pathways to control UV sensitivity. Figure 1.Histone H3K36 demethylase Rph1 regulates the transcription of *PHR1*. (**A**) Left: The *rph1Δ* strains carrying constitutively overexpressed *RPH1* or control 2-µ vector were streaked on selective plate. Right: The UV-sensitivity test was performed with indicated strains. Cells were spotted on plates containing galactose or glucose with 5-fold serial dilution and subjected to UV irradiation. Asterisks denotes the constitutive expression of *RPH1* with its own promoter in 2-µ vector. (**B**) UV sensitivity was tested with indicated strains. Yeast strains (WT, histone mutants, *rph1Δ* and *set2Δ*) grown in glucose in log-phase or induced with galactose for 4 h were spotted on selective plates. (**C**) *PHR1* expression in WT, *rph1Δ* and *set2Δ* strains. The cells were cultured to early log phase and subjected to 20 mj/cm^2^ UV irradiation. RT--qPCR was performed and transcription of *PHR1* of each strain was normalized to *ACT1*. Error bars indicate the SD from three biological repeats. (**D**) *PHR1* level in WT or *rph1Δ* yeast containing control vector (Vector), WT *RPH1* or H235A-mutated *RPH1* under different promoters before or after 20 mJ/cm^2^ UV irradiation (right). Error bars are the SD of five biological replicates. \**P* \< 0.05.

Because Rph1 was originally identified as a repressor of the DNA repair gene *PHR1*, we sought to elucidate whether the demethylase activity is linked to the transcriptional regulation of *PHR1*. RT-qPCR was used to measure the levels of *PHR1* expression in the WT and *rph1*-deletion (*rph1Δ*) and *set2*-deletion (*set2Δ*) strains treated with UV irradiation. Deletion of *rph1* led to approximately 2-fold enhancement of *PHR1* ([Figure 1](#F1){ref-type="fig"}C) under normal conditions (−UV). These results agree with a previous report that Rph1 is a repressor of *PHR1* expression ([@B23]). Surprisingly, lack of Set2 did not interfere with the expression of *PHR1* ([Figure 1](#F1){ref-type="fig"}C), which suggests that Set2 methyl-transferase plays a minor role in *PHR1* expression. Although *set2Δ* increased the UV sensitivity ([Figure 1](#F1){ref-type="fig"}B, middle panel), our results suggest that Set2 may regulate factors other than *PHR1* that are involved in UV response such as the DNA repair gene *RNR3* ([@B40],[@B41]).

To investigate the role of Rph1 in *PHR1* expression, we used three different promoters, representing an inducible (*GAL1*), a constitutive (*CEN-GPD1*), or a native promoter (*CEN-RPH1*), to express *RPH1* in the *rph1Δ* background. In addition to WT *RPH1*, a catalytic-deficient *rph1* (*rph1-H235A*) was expressed by the aforementioned promoters to determine the involvement of demethylase activity ([Figure 1](#F1){ref-type="fig"}D). In the absence of UV treatment (−UV), the expression of *RPH1* by any of the three promoters was sufficient to suppress *PHR1* expression, which is higher in *rph1Δ* (vector) than in the WT ([Figure 1](#F1){ref-type="fig"}D). In contrast, *PHR1* expression in the *rph1-H235A* mutant did not significantly differ from that in *rph1Δ* ([Figure 1](#F1){ref-type="fig"}D), which indicates that the histone H3K36 demethylase activity of Rph1 is required to suppress *PHR1* expression.

In response to UV irradiation, *PHR1* expression was induced ranging from 2.5- to 3.4-fold in *rph1Δ* ([Figure 1](#F1){ref-type="fig"}D, 'Vector+UV') as compared to that in WT ([Figure 1](#F1){ref-type="fig"}D, 'WT−UV', defined as 1), which indicates that Rph1 represses *PHR1* expression in the absence of DNA damage*.* However, the levels of *PHR1* expression with UV irradiation were induced in both *RPH1* and *rph1-H235A* under control of the three promoters ([Figure 1](#F1){ref-type="fig"}D), which suggests that histone H3K36 demethylation-independent pathways are involved in the transcriptional activation of *PHR1* responding to UV damage signal. Taken together, these data suggest that the demethylase activity of Rph1 plays an important role in the repression of *PHR1* expression, rather than the UV-inducible transcriptional activation.

Rph1 binds to the URS of *PHR1* through ZF domains and modulates chromatin modifications in specific regions of the *PHR1* promoter
-----------------------------------------------------------------------------------------------------------------------------------

We have previously demonstrated that Rph1 plays a major role in transcriptional repression of *PHR1* ([Figure 1](#F1){ref-type="fig"}). We next used ChIP assays to evaluate whether the Rph1-mediated repression of *PHR1* affects the chromatin structure. The primary protein-coding gene structure of *PHR1* is illustrated in [Figure 2](#F2){ref-type="fig"}A (upper panel). We first determined whether deletion of *RPH1* changed the H3K36 tri-methylation at the *PHR1* gene region ([Figure 2](#F2){ref-type="fig"}A, lower panel). To confirm the specificity of the H3K36me3 signal, we used *set2Δ* and H3K36A mutants for H3K36me3-ChIP and found extremely low levels of H3K36me3 in *set2Δ* and H3K36A mutants as compared with that in WT and *rph1Δ.* Interestingly, *rph1Δ* showed an increased level at the promoter of *PHR1* but not the 3′ coding region of *PHR1*, suggesting that Rph1-mediated demethylation participates in the regulation of *PHR1* promoter activity. We next investigated whether Rph1 is physically associated with chromatin *in vivo*. To determine the temporal regulation of *PHR1* expression by Rph1, we used the inducible *GAL1* promoter to analyze the immediate effect of overexpressed Rph1 on the transcriptional regulation of *PHR1*. ChIP assays were performed to detect the relative abundance of HA-tagged Rph1 and H3K36me3 at the *PHR1* promoter region containing a 300 bp 5′-upstream sequence ([Figure 2](#F2){ref-type="fig"}B). In agreement with *in vitro* electrophoretic mobility shift assay (EMSA) and footprinting analyses, which demonstrated that Rph1 binds to a specific *PHR1* promoter sequence ([@B23]), our ChIP analysis also revealed that Rph1 binding was enriched at the *PHR1* promoter by at least 4-folds in both the WT (*RPH1*) and mutant *rph1-H235A* as when compared with that ine *rph1Δ* mutant (vector alone) ([Figure 2](#F2){ref-type="fig"}B, HA-IP). However, only the WT Rph1 but not the *rph1-H235A* reduced H3K36 tri-methylation ([Figure 2](#F2){ref-type="fig"}B, H3K36me3-IP), which indicates that the enzymatic activity of Rph1 is required for H3K36 demethylation at the promoter of *PHR1*. This result was not merely due to the induced overexpression of Rph1 by the *GAL1* promoter because we also found similar results by using the *GPD1* promoter to drive a constitute expression of Rph1 in a low-copy (*CEN*) plasmid ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)). Therefore, Rph1 is associated with the promoter of *PHR1* resulting in a decreased H3K36 methylation to influence transcriptional repression. Figure 2.Rph1 binds to the upstream repression sequence (URS) of *PHR1* through ZF domains. (**A**) Top panel: The schematic representation of primers specific to different regions on *PHR1* for PCR. +1 indicates the transcription start site of *PHR1*. The primer sequences are in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1). Lower panel: The specificity of H3K36me3 at the *PHR1* promoter and coding region were detected by ChIP in WT, *rph1Δ, set2Δ* and H3K36A mutants. Bar graph represents the quantified results from three biological repeats. (**B**) ChIP with anti-HA and anti-H3K36me3 antibodies were performed with the indicated strains. The right panels show the fold change relative to the control (vector), which was normalized by input. (**C**) The ZF domains are required for transcriptional repression on *PHR1* and for specific association with URS*~PHR1~*. Left panel: *PHR1* expression in *rph1Δ* (vector), induced WT *RPH1* or ZF-deleted *RPH1* (ZF*Δ*). \*\*\**P* \< 0.001 compared with vector. Right panel: ChIP with anti-HA antibody at the UAS or URS regions. Data are from three different biological samples.

Because histone H3K36 demethylation is involved in transcriptional repression at the *PHR1* promoter, we next identified the specific region of the *PHR1* promoter associated with Rph1 and the specific domain of Rph1 required for chromatin association. Three putative *cis*-elements of *PHR1* promoter were characterized previously by β-galactosidase assays: an upstream activation sequence (UAS*~PHR1~*), a novel essential sequence (UES*~PHR1~*) and an upstream repression sequence (URS*~PHR1~*) ([@B25]). To define the Rph1-controlled transcriptional events, we used a series of ChIP experiments with primers to amplify specific regions of the *PHR1* promoter (URS*~PHR1~*, 78∼−40; and UAS + UES*~PHR1~*, 152∼−96). Results from ChIP assays with anti-HA (Rph1) uncovered that Rph1 was specifically associated with the URS (URS*~PHR1~*) but not the UAS (UES + UAS*~PHR1~*) region ([Figure 2](#F2){ref-type="fig"}C).

A C-terminal domain of Rph1 is required for DNA binding *in vitro* ([@B23]). We attempted to dissect the essential motif of Rph1 required for the DNA binding affinity *in vivo*. Domain analysis by *SMART* (<http://smart.embl-heidelberg.de/>) predicted that Rph1 contains two ZFs at the C-terminus that may contribute to DNA binding. We introduced a ZF-domain deleted Rph1 construct (ZFΔ) into the *rph1Δ* strain and found a higher expression level of *PHR1* than that in WT (*RPH1*) ([Figure 2](#F2){ref-type="fig"}C, left panel). ChIP assays with anti-HA (Rph1) further demonstrated that ZF deletion reduced the binding of Rph1 with the URS*~PHR1~* region, which was negatively correlated to the expression level of *PHR1* ([Figure 2](#F2){ref-type="fig"}C, right panel). Therefore, the ZF domains of Rph1 directed its DNA binding and transcriptional repression *in vivo*.

Crosstalk between H3K36 tri-methylation and H3 acetylation occurs at the *PHR1* promoter
----------------------------------------------------------------------------------------

The synergistic crosstalk of histone modifications has been suggested as an important regulatory mechanism in gene expression ([@B33],[@B42],[@B43]). We hypothesized that gene-specific synergistic histone modifications also take place on the *PHR1* promoter by interacting with DNA-bound transcription factors. Because Rph1 bound to the URS*~PHR1~* but not UES + UAS*~PHR1~* region ([Figure 2](#F2){ref-type="fig"}C) and consequently decreased H3K36 methylation in the absence of UV irradiation, we examined whether histone H3K36 demethylation affected histone acetylations. Results from ChIP assays with anti-acetylated histone H3K9/14 (acH3) and H4K5/8/12/16 (acH4) revealed that Rph1 altered histone acetylation in different regions ([Figure 3](#F3){ref-type="fig"}A). The levels of histone H3/H4 acetylations were reduced by about 50% only at the URS*~PHR1~* but not the UAS*~PHR1~* or coding region ([Figure 3](#F3){ref-type="fig"}A). Thus, the association of WT Rph1 at URS*~PHR1~* reduced the histone acetylations in this region. Furthermore, the catalytic-deficient *rph1-H235A* mutant displayed patterns similar to those of the *rph1Δ* (vector) in histone acetylations, which indicates that Rph1 demethylase activity is critical for the crosstalk of histone modifications at the *PHR1* promoter. The reduced histone acetylation implies an involvement of histone deacetylase(s). To examine this possibility, we performed acH3-ChIP using various histone deacetylase (HDAC)-deleted strains, including *HDA1, HDA2* (Type II) and *RPD3* (Type I), in the presence of overexpressed *RPH1*. Lack of *RPD3* restored the H3 acetylation level at the URS*~PHR1~* in the presence of Rph1 ([Figure 3](#F3){ref-type="fig"}B). Moreover, results from ChIP experiments revealed the significant association of Rpd3 at the URS*~PHR1~* but not the UAS*~PHR1~* region in the presence of Rph1 ([Figure 3](#F3){ref-type="fig"}C), which indicates that Rpd3 specifically deacetylated histones at the URS*~PHR1~* region responsible for the transcriptional repression of *PHR1*. Figure 3.Demethylation at H3K36 coexists with a reduction of histone acetylations specifically at the URS of *PHR1*. (**A**) Histone H3/H4 acetylation was altered at the URS and coding region of *PHR1*. ChIP-qPCR from the indicated strains was performed with anti-AcH3 and anti-AcH4. \**P* \< 0.05. Data are from three biological repeats. (**B**) *RPD3* deletion restored the reduction of H3 acetylation at the URS. Indicated HDAC deletion strains with overexpressed Rph1 were harvested for acH3-ChIP. (**C**) Rpd3-Myc is associated at URS region in the presence of Rph1. The *rph1Δ* cells containing control vector or overexpressed Rph1 with Myc-tagged Rpd3 were harvested for Myc-ChIP and qPCR. Error bars represents the SD from two biological repeats. (**D**) Left: H3K36A showed the reduction of H3 acetylation at the URS of *PHR1*. Cells carrying WT or H3K36 mutated (H3K36A) histones were subject to acH3-ChIP followed by qPCR. Right: *PHR1* expression in WT or H3K36A mutant. (**E**) ChIP with anti-Rpb3 at URS region of *PHR1* in WT, *rph1Δ, set2Δ* and H3K36A mutants. Error bars shows the SD from two biological samples.

To confirm the crosstalk between histone methylation and acetylation, we performed acH3-ChIP experiments in WT yeast and the H3K36A mutant. Reduced acetylation was revealed exclusively at the URS*~PHR1~* region in the H3K36A mutant ([Figure 3](#F3){ref-type="fig"}D, left panel); therefore, Rph1 suppresses *PHR1* expression by modulating the chromatin structure in a demethylase-dependent manner. Our current findings support that the Rph1-mediated H3K36 demethylation and crosstalk with histone acetylation also take place at the *PHR1* promoter to regulate gene transcription. To determine whether the promoter association of Rph1 and the crosstalk of histone modifications are specific to the *PHR1* gene, we performed ChIP assay with anti-acetylated histone H3 (acH3) and Rph1-HA at the *ADH1* promoter. However, we did not find a significant difference in H3 acetylation or Rph1 association on the *ADH1* promoter and coding region ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)).

The recruitment of RNA polymerase II (Pol II) to promoters to initiate transcription has been the central dogma in regulation of active gene expression. However, recent studies from genome-wide analysis revealed that Pol II is associated with the promoters of many non-actively transcribed genes in murine embryonic stem cells and *Drosophila* ([@B44],[@B45]). To determine the preoccupancy of Pol II at the repressed *PHR1* promoter, we performed ChIP experiments with Rpb3 (a subunit of RNA Pol II core complex). Binding of Pol II at the URS*~PHR1~* region was reduced in the H3K36A mutant but remained unchanged in the *set2Δ* mutant as compared with the WT ([Figure 3](#F3){ref-type="fig"}E). The binding was only slightly increased in the *rph1Δ* mutant. Thus, Rph1 and modification of H3K36 but not Set2 regulate the pre-occupancy of Pol II at the *PHR1* promoter. Rph1 likely specifically binds and modulates histone methylation and acetylation and consequently influences Pol II recruitment at the URS*~PHR1~* region.

Rph1 is dissociated from the *PHR1* promoter in response to DNA damage
----------------------------------------------------------------------

In response to DNA damage, transcriptional induction of *PHR1* should require *a priori* de-repression. Previously, Rph1 was named photolyase regulatory protein (PRP), which bound to the *PHR1* URS and regulated the induction of *PHR1* transcription after DNA damage ([@B24]). We performed ChIP assays to study the dynamics of Rph1 in response to DNA damage *in vivo*. After UV irradiation, the association of both Rph1 and the *rph1-H235A* mutant was significantly decreased, which suggests that Rph1 was released from the promoter of *PHR1* after DNA damage ([Figure 4](#F4){ref-type="fig"}A). To determine whether the protein level of Rph1 was affected by DNA damage, Rph1-HA expression was analyzed by immunoblotting (IB; [Figure 4](#F4){ref-type="fig"}A). Rph1 levels were only slightly decreased after UV irradiation, which suggests that the dissociation from the promoter cannot simply be attributed to protein expression levels of Rph1 and *rph1-H235A*. The quantitative-ChIP results also confirmed the association and dissociation of Rph1 at the *PHR1* promoter *in vivo* ([Figure 4](#F4){ref-type="fig"}B). Figure 4.Rph1 is dissociated from *PHR1* promoter in response to UV irradiation. (**A**) The indicated strains were irradiated (UV: 20 mJ/cm^2^) and harvested for ChIP with anti-HA antibody. IB with anti-HA antibody showed the expression of Rph1. Anti-Pgk1 was the loading control and the ratio of Rph1/Pgk1 is indicated. (**B**) The quantitative result is shown from comparable samples in (A). (**C**) ChIP assay from samples in (A) with anti-H3K36me3 and anti-acH3 antibodies was followed by qPCR to monitor the URS region signals. Data are from three biological repeats. \**P* \< 0.05.

We further examined the synergistic crosstalk of chromatin modifications in the repressed *PHR1* promoter in response to UV irradiation. We monitored histone acetylation and methylation levels at the URS*~PHR1~* before and after UV irradiation by ChIP with antibodies against H3K36me3 and acH3. The level of H3K36me3 was elevated slightly in the presence of *RPH1* but not in *rph1Δ* (vector) or in the *rph1-H235A* mutant by UV treatment ([Figure 4](#F4){ref-type="fig"}C, left panel). However, in the presence of UV irradiation (+UV), the levels of histone H3 acetylation were comparable among *RPH1*, *rph1-H235A* and *rph1Δ* (vector) at the URS*~PHR1~* region ([Figure 4](#F4){ref-type="fig"}C, right panel). These results suggest that dissociation of Rph1 responding to UV irradiation results in an elevated level of histone acetylation. Furthermore, our observation demonstrated that dynamic interaction of Rph1 on the promoter of *PHR1* plays a role in H3K36 demethylation and histone acetylation to regulate *PHR1* expression in response to DNA damage.

Methylation at H3K36 mediated by Set2 plays a major role in transcriptional elongation ([@B18],[@B46],[@B47]), which was suggested to involve the H3K36 demethylase Rph1 ([@B15],[@B20]). To investigate the role of H3K36 demethylation in transcriptional elongation, we used ChIP of the transcribed region with primers specific to 5′ (11--349) and 3′ (907--1434) coding regions of *PHR1*. Surprisingly, in the coding regions, the relative HA-IP signals were similar to those for *rph1Δ* (vector), which indicates no enhancement of Rph1 binding, yet H3K36 methylation was still decreased ([Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)). It is possible that the histone H3K36 methylation is transient or too weak to be detected by ChIP in the coding region. Our observations are similar to results of study of *ADH1, PMA1* and *YEF3* genes ([@B20]). However, the detailed mechanism for the demethylation in the coding regions remains to be established.

Rad53 regulates the expression of *PHR1* and dissociation of Rph1 in response to DNA damage
-------------------------------------------------------------------------------------------

It has been suggested that Rph1 phosphorylation is under the control of the Mec1-Rad53 damage checkpoint pathway but distinct from the Dun1-Crt1 pathway ([@B48]). In budding yeast, Rad53, the ortholog of mammalian Chk2, is a crucial checkpoint protein, and Dun1 is considered the main downstream kinase of Rad53 responding to DNA damage ([@B49],[@B50]). However, the connection between the expression of *PHR1*, a DNA repair gene and Rad53 is still unknown. To examine whether Rad53 plays a regulatory role in *PHR1* expression in DNA damage signaling, we analyzed the *PHR1* transcription level in a *rad53Δ* strain. Deletion of *RAD53* is lethal. Therefore, we evaluated the role of *RAD53* by using a *rad53Δ sml1Δ* strain, which loss of *SML1* suppresses the lethality of *RAD53* deletion ([@B51]). By using RT--qPCR analysis, we found the expression level of *PHR1* in the absence of UV irradiation decreased by 30% in the *rad53Δ* mutant but not in the *dun1Δ* mutant ([Figure 5](#F5){ref-type="fig"}A). With UV irradiation (30 mj/cm^2^), the induction of *PHR1* was reduced by 35% in the *rad53Δ* mutant but only slightly in the *dun1Δ* strain. The Rad53-Dun1-regulated gene *HUG1* was not induced in either the *rad53Δ* or *dun1Δ* mutant ([Figure 5](#F5){ref-type="fig"}A, right panel). Therefore, our data demonstrate that an efficient *PHR1* expression requires *RAD53* but is less dependent on *DUN1*. Figure 5.Rph1 regulates transcription of *PHR1* mediated by Rad53 in response to DNA damage. (**A**) The expression of *PHR1* and *HUG1* in *sml1Δ* (WT)*, sml1Δ rad53Δ* (*rad53Δ*) and *sml1Δ dun1Δ* (*dun1Δ*) mutants responding to different doses of UV irradiation. *HUG1* was used as an indicator of intact DNA damage signaling. \**P* \< 0.05. (**B**) UV-sensitivity test of indicated strains in the *rph1Δ rad53Δ* background with different combinations of control vector, overexpressed *RAD53* or kinase-dead (KD) and WT *RPH1*. (**C**) *PHR1* expression of strains as in (B). Cells harvested from early-log phase underwent 30 mJ/cm^2^ irradiation. ^\*,\ \#,\ §^*P* \< 0.05. (**D**) ChIP with anti-Rph1 (HA) at URS from comparable samples as in [Figure 4](#F4){ref-type="fig"}C. Bar graphs show qPCR results in URS of *PHR1* promoter. IB indicated the protein expression of Rph1, and Pgk1 is a loading control. All RT-qPCR data are at least from three different biological samples. Results of ChIP are from 2 biological samples. \**P* \< 0.05.

To further address the interplay between Rad53 and Rph1 for *PHR1* expression, we performed genetic epistasis analysis. We generated the triple deletion strain (*rad53Δ rph1Δ sml1Δ*) as the genetic background for overexpression of Rad53, Rph1 or both in yeast. UV sensitivity assays and RT--qPCR analysis were used to evaluate the functional relationship between Rad53 and Rph1. In the absence of Rph1, overexpression of the WT Rad53, but neither kinase-dead (*rad53-KD*) nor control vector (*rad53Δ*), restored the growth of *rad53Δ* in response to UV irradiation ([Figure 5](#F5){ref-type="fig"}B). Furthermore, overexpression of WT Rph1 enhanced the UV sensitivity, whereas expression of WT Rad53, but not kinase-dead (*rad53-KD*) or control vector (*rad53Δ*), compensated the defective growth phenotype ([Figure 5](#F5){ref-type="fig"}B). Therefore, Rad53 may be involved in the regulation of *PHR1* expression in response to UV irradiation, possibly through modulating Rph1 function. To understand the effect of Rad53 on Rph1 in regulating gene transcription, we analyzed the expression of *PHR1* in the absence or presence of Rad53 and Rph1 ([Figure 5](#F5){ref-type="fig"}C). The basal transcription of *PHR1* remained high in *rph1Δ*, regardless of the presence of Rad53 (asterisks and hash symbols in [Figure 5](#F5){ref-type="fig"}C). Overexpression of WT Rph1 reduced the basal transcription of *PHR1* to 68% (asterisks in [Figure 5](#F5){ref-type="fig"}C). In the presence of overexpressed Rph1, Rad53 could enhance the basal expression of *PHR1* (section symbol in [Figure 5](#F5){ref-type="fig"}C), whereas UV-induced damage slightly increased the transcription of *PHR1*. To further elucidate the relation among Rph1, Rad53 and UV irradiation in regulating *PHR1* expression, the data were subjected to regression analysis ([Table 1](#T1){ref-type="table"}). Rph1 is the most effective factor suppressing the transcription of *PHR1* (standardized coefficient of Rph1: −0.738), whereas Rad53 and UV irradiation play a moderate but positive role in regulating *PHR1* (standardized coefficient of Rad53 and UV: 0.453 and 0.375, respectively). These observations ([Figure 5](#F5){ref-type="fig"} and [Table 1](#T1){ref-type="table"}) indicate that Rph1 is the major regulator of *PHR1* under experimental conditions and emphasize the role of the checkpoint protein Rad53 in the modulation of Rph1 during the regulation of *PHR1*. Table 1.Regression analysis to evaluate the effective strength to *PHR1* expressionModelUnstandardized coefficientsStandard. errorStandardized coefficients*t*SignificanceBβ(Constant)0.9690.04123.833.71e-01RPH1−0.4050.041−0.738−9.9463.47e-00RAD530.2480.0410.4536.1085.72e-00UV0.2060.0410.3755.0546.07e-00[^1][^2]

To determine the role of Rad53 in regulating *PHR1* expression, we used ChIP analysis to examine the effect of Rad53 on the recruitment of Rph1 and the levels of H3K36me3 at the URS*~PHR1~*. In the absence of UV irradiation, Rph1 was associated with URS*~PHR1~*, as shown above, regardless of the presence of Rad53 ([Figure 5](#F5){ref-type="fig"}D, black bars). Distinct from our previous observation that Rph1 dissociated from the URS*~PHR1~* after UV irradiation ([Figure 3](#F3){ref-type="fig"}A), Rph1 remained bound to URS*~PHR1~* in the absence of Rad53 (asterisksin [Figure 5](#F5){ref-type="fig"}D), which strongly indicates that Rad53 functions as a crucial regulator for Rph1 to dissociate from *PHR1* promoter upon UV irradiation ([Figure 5](#F5){ref-type="fig"}D). Furthermore, the levels of H3K36me3 and H3 acetylation are correlated to the presence of Rph1 at the URS*~PHR1~* region ([Supplementary Figure S5](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)). Chromatin-bound Rph1 retained low levels of histone H3K36 tri-methylation in the *rad53Δ* strain after DNA damage. ChIP analysis indicated that Rad53 was required for the dissociation of Rph1 from URS*~PHR1~*. Our results suggest a potentially novel damage checkpoint pathway that is directed by a Rad53-Rph1 cascade of regulatory events.

Activated Rad53 complex phosphorylates Rph1 and S652A-mutated Rph1 impairs the dissociation in response to DNA damage
---------------------------------------------------------------------------------------------------------------------

To test whether Rph1 is a substrate of Rad53, we performed an *in vitro* kinase assay by incubating IP-activated Rad53 (WT or KD) with recombinant Rph1. By autoradiography, we detected a specific signal of Rph1 phosphorylation in the presence of WT Rad53 but not rad53-KD, which established that Rad53 kinase dominated the phosphorylation of Rph1 ([Figure 6](#F6){ref-type="fig"}A). Previous proteomic studies had revealed that Rph1 was phosphorylated at multiple serine residues induced by DNA damage or cell cycle arrest ([@B52; @B53; @B54; @B55]). To determine the functional role of phosphorylation, we generated a series of alanine-substituted mutations on putative phosphorylated serine residues (S412, S459, S557, S561, S652 and S689) to analyze the UV sensitivity of these mutants. Because the Rph1 phosphorylation triggered by, UV irradiation may reflect a transient response, we attempted to examine the immediate response by use of the *GAL* inducible expression system. However, we found severe growth defects in the WT and phospho-mutants of Rph1 ([Figure 1](#F1){ref-type="fig"}A and [Supplementary Figure S6](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)) cultured on synthetic complete selective medium in the presence of galactose (SCM-URA + galactose) but not glucose (SCM-URA + glucose), presumably because of constitutively overexpressed Rph1. To avoid this potential issue to obscure the growth phenotype, we modified our experimental protocol to use the *GAL1* promoter to induce the overexpression of the WT and phospho-mutants of Rph1 4 h before UV irradiation, then scored the phenotype 2 days later (see 'Methods and Materials' section). When the UV dose was increased to 30 mJ/cm^2^, we found that the *rph1-S652A* mutant began to show a hypersensitivity to UV irradiation, even greater than that of Rph1 overexpression ([Figure 6](#F6){ref-type="fig"}B, [Supplementary Figure S7](http://nar.oxfordjournals.org/cgi/content/full/gkr040/DC1)). From bioinformatics studies (*Scansite*, <http://scansite.mit.edu/and> GPS2.1, <http://gps.biocuckoo.org/>), we selected S459 (embedded within the putative bipartite nuclear localization region) and S652 (a consensus phosphorylated site detected in genome-wide LC/MS analysis) ([@B52; @B53; @B54; @B55]) to further characterize the functional role of Rph1 phosphorylation in *PHR1* expression. The *rph1-S459A* mutant displayed a similar UV-sensitivity phenotype to WT Rph1, whereas *rph1-S652A* and *rph1-S459AS652A* mutants were hypersensitive to UV irradiation ([Figure 6](#F6){ref-type="fig"}B), which indicates that phosphorylation at S652 may play a critical role in Rph1 function responding to DNA damage. We subsequently measured the expression of *PHR1* and association of Rph1 phospho-mutants with URS*~PHR1~*. The expression levels of *PHR1* were comparable in *rph1-S459A* and WT Rph1 but were reduced to 30% (*P* \< 0.05) in *rph1-S652A* and *rph1-S459AS652A* mutants, regardless of UV treatment ([Figure 6](#F6){ref-type="fig"}C). Remarkably, results from HA (Rph1)-ChIP assays showed that S652A mutation did not affect the Rph1 association with URS*~PHR1~* but greatly impaired the dissociation from URS*~PHR1~* on UV treatment ([Figure 6](#F6){ref-type="fig"}D), which indicates that phosphorylation at S652 is important for Rph1 to dissociate from URS*~PHR1~* in the presence of UV irradiation. These data support that chromatin association and dissociation of Rph1 on the *PHR1* promoter mediated by protein phosphorylation is the major regulatory mechanism for *PHR1* expression responding to DNA damage. Figure 6.The phospho-mutant at S652 of Rph1 increases UV sensitivity and impairs the dissociation after UV irradiation. (**A**) *In vitro* kinase assay was performed by recombinant Rph1 or BSA incubated with or without V5-IP WT or KD Rad53 supplied by γ^32^P-ATP. The signal was detected by autoradiography. pRad53 indicated the autophosphorylation of Rad53. pRph1 indicated the phosphorylation of Rph1. Coomassie Blue and immnoblotting (anti-V5) showed the loading controls. (**B**) UV sensitivity of *rph1Δ* cells containing control vector, WT Rph1 (*RPH1*) or phospho-defective Rph1 mutants. (**C** and **D**) The indicated strains as in (B) were harvested for RT-qPCR to detect *PHR1* expression in response to UV or not (C) and for HA-ChIP to measure the association of Rph1 at URS of *PHR1* (D). Error bars show the SD of three biological repeats. \**P* \< 0.05.

DISCUSSION
==========

Collectively, we hypothesize a model to describe the regulatory event modulated by the H3K36 demethylase Rph1 at the *PHR1* promoter in response to DNA damage signals in [Figure 7](#F7){ref-type="fig"}. Roeder proposed a model of a 'two-step process' of transcriptional activation in eukaryotes: (i) The overall level of induction in response to activating signal involving first a 'de-repression step' that restores activity to the basal level, and followed by (ii) A 'net-activation' step that leads to the higher induction expression level ([@B56]). Here, we show that Rph1-mediated H3K36 demethylase activity is required to repress *PHR1* expression and is involved in regulating the early step of transcriptional activation. Rph1 is specifically associated with URS*~PHR1~* to generate a repressed or ground state of chromatin structure in the absence of UV irradiation. The physiological repressed chromatin structure at the URS*~PHR1~* subsequently leads to decreased histone acetylation by cooperatively associating with the Rpd3 co-repressor complex. The checkpoint kinase Rad53 is required for the basal and inducible expression of *PHR1*. Upon UV-induced DNA damage, the fully activated Rad53 modulates the phosphorylation of Rph1, which subsequently dissociates from URS*~PHR1~* to relieve the suppressed expression of *PHR1*. In addition, Rad53 may mediate the recruitment of other co-activators to increase the histone acetylations at the promoter in response to UV irradiation, which induces *PHR1* expression for efficient DNA repair. This study highlights a distinct mechanism of the histone demethylase in transcriptional regulation at the promoter region instead of coding sequence. Thus, we reveal that the key regulatory step of Rph1 is to maintain a low level of H3K36 methylation at the *PHR1* promoter in the basal state. Dismissal of Rph1 from the URS*~PHR1~* region is mediated by a DNA damage signal to allow immediate histone acetylations as well as transcriptional initiation by recruiting RNA pol II. Figure 7.A model for Rph1-regulated *PHR1* expression in response to DNA damage. Under normal conditions, Rph1 associates with URS*~PHR1~*, and *PHR1* transcription is repressed (upper panel). Under DNA damage signaling, Rph1 dissociates from the *PHR1* promoter to induce the expression of *PHR1.* Ac, histone acetylation; Me, H3K36 tri-methylation; Pi, phosphorylation; See 'Discussion' section for details.

Histone H3K36 demethylase activity cooperates with DNA-binding affinity of Rph1 in the repression of *PHR1* transcription
-------------------------------------------------------------------------------------------------------------------------

Given the genome-wide distribution of histone modifications, H3K36me3 is enriched in the transcribed region of generally active genes ([@B57]). A major question concerns the mechanism of transition from methylation--demethylation involving in the transcriptional repression to activation. The transitions could be a simple matter of equilibrium enzyme reactions, the histone methyltransferases (HMTs) and histone demethylases (JHDMs). Kim and Buratowski ([@B20]) reported that JHDMs (Jhd1 and Rph1) antagonize Set2-mediated H3K36 methylation and promote transcription elongation in constitutively highly expressed genes, and such equilibrated events take place in the coding region of genes. Here, we studied a DNA damage-inducible gene, *PHR1,* which is repressed under normal growth conditions. Different from previous findings, our results reveal that H3K36 demethylase Rph1 functions as a repressor and associates at the promoter of *PHR1* in the absence of DNA damage signals. Defective H3K36 methylation, lack of Set2 and overexpression of Rph1 ([@B39],[@B40]) increased the sensitivity to UV irradiation. However, deletion of *SET2* did not affect the expression of *PHR1* under our experimental conditions, whereas overexpression of Rph1 and H3K36A mutant strains decreased the expression level of *PHR1*.

Three possibilities may serve to explain our observations. The first is that Set2-mediated H3K36 methylation is not required to initiate basal transcription of *PHR1* under the normal condition (−UV). The genome-wide distribution profile of H3K36 methylation at promoters is relatively lower than that in coding regions. Therefore, an increase in level of H3K36 methylation at specific promoters is likely due to a decreased activity of histone demethylase, such as Rph1 ([Figure 2](#F2){ref-type="fig"}A), rather than the recruitment of HMT activity (Set2) to add methyl groups to H3K36. The second explanation is based on the recruitment of RNA Pol II at the promoter region. Pol II was found to occupy inactive promoter regions of signal-inducible genes, named PRGs (primary response genes). These genes are regulated at the transition between de-repression and transcriptional initiation in the basal state by an interplay with a co-repressor complex. Most PRG promoters have a high basal level of H3K4me and H3K9Ac ([@B58]). Indeed, we demonstrated that Pol II binding at the *PHR1* promoter is decreased in the H3K36A mutant but not the *set2Δ* strain ([Figure 3](#F3){ref-type="fig"}E), which implies a distinct role of Set2 in Pol II recruitment at the promoter and coding regions. H3K36A mutant may change the level of histone H3K9/14 acetylation by an unknown mechanism ([Figure 3](#F3){ref-type="fig"}D) and consequently affect Pol II recruitment at the *PHR1* promoter. The third possibility is a temporal dependency of other modifications on H3K36 such as lysine acetylation. Recent studies demonstrated that H3K36 can be modified by Set2-mediated methylation and Gcn5-dependent acetylation ([@B59]). Acetylation at H3K36 is localized predominantly at the promoters of RNA polymerase II-transcribed genes and functions as a prelude to transcriptional initiation ([@B59],[@B60]). The *set2Δ* eliminated only H3K36 methylation, and H3K36A wiped out both methylation and acetylation at the *PHR1* promoter. These observations suggest that the transition between H3K36ac and H3K36me represents a novel 'dual-modification chromatin switch' that controls the regulation of gene transcription at the *PHR1* promoter. The functional complexity of both acetylation and methylation, but not simultaneously, on H3K9 is an example of the 'dual-modification chromatin switch'. The recruitment of chromodomain protein HP1 to initiate the formation of heterochromatin depends on H3K9 methylation in mammals and fission yeast ([@B61],[@B62]). We hypothesize that the interplay among acetylation, deacetylation, methylation and demethylation at the same site can also occur on H3K36 at the *PHR1* promoter in budding yeast. None of the three suggested mechanisms above are mutually exclusive and all could act cooperatively.

Set2-dependent H3K36 methylation is required for Rpd3C(S) recruitment co-transcriptionally to the coding region for transcriptional activation ([@B63]). Surprisingly, our results indicate that Set2 plays a minor, if any, role in transcriptional activation of *PHR1*. However, our finding is not an isolated case. The expression of the starvation-induced genes *ARG1* and *HIS4* does not depend on Set2-mediated methylation at H3K36 ([@B64],[@B65]). Our results may add *PHR1* to this list.

Multiple lines of evidence suggest that chromatin modifications play a complex role in the regulation of transcription. The crosstalk between histone modifications can facilitate or repress chromatin-mediated processes ([@B3]). Here, we show that the histone H3K36 demethylation is linked to reduced histone acetylation involving the histone deacetylase Rpd3 at the *PHR1* promoter ([Figure 3](#F3){ref-type="fig"}B and C). Furthermore, Rph1 and Rpd3 can associate with URS*~PHR1~*, which may form the Ume6-Rpd3-Rph1 co-repressor complex and consequently block the UAS*~PHR1~* for basal *trans*-activation. Moreover, Rph1-mediated H3K36 demethylation at URS*~PHR1~* may specify a histone mark to recruit a co-repressor complex or prevent the recruitment of a co-activator that consequently silences *PHR1* expression in the absence of UV damage.

Alternatively, the variation in histone acetylation may be due to the recruitment of HATs. Many studies of gene expression involving genome-wide approaches or focusing on individual genes suggest that the histone acetylases Gcn5 (SAGA complex) and Esa1 (NuA4 complex) are generally recruited to the promoters of protein-coding active genes ([@B66]). Here, we observed that Rph1 was dissociated from the URS*~PHR1~* region and cooperatively increased acetylation of histone H3/H4 after UV irradiation ([Figure 4](#F4){ref-type="fig"}A). The dissociation of a putative Rph1/co-repressor complex ([Figure 4](#F4){ref-type="fig"}C), as well as deletion of *RPH1* ([Figure 1](#F1){ref-type="fig"}C), may provide a more accessible region for the HAT complex to target at the URS*~PHR~* to enrich acetylations on chromatin for subsequent transcriptional activation. These observations imply that dissociation of demethylase at the promoter influences the chromatin dynamics.

Rad53 kinase activity and S652 phosphorylation of Rph1 are required for the dissociation of Rph1 in response to DNA damage
--------------------------------------------------------------------------------------------------------------------------

We demonstrate that the activated Rad53 complex mediates the Rph1 phosphorylation in response to DNA damage. Rad53 regulates the chromatin binding of Rph1 as well as enrichment of H3K36 methylation at the URS*~PHR1~* region ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). In addition, we provide *in vivo* evidence of the functional role of phosphorylation in a histone demethylase, Rph1. Abolishment of the phosphorylation at S652 (*rph1-S652A*) had important biological impacts, as indicated by the significant differences in UV sensitivity, *PHR1* repression and Rph1 binding to *PHR1* promoter ([Figure 6](#F6){ref-type="fig"}B and C). Phosphorylation is linked to protein function, such as conformational change, stability and activity. Phosphorylation on transcription factors can regulate the chromatin association and biological functions. A recent study of the *Methyl-CpG Binding Protein 2* (*MECP2*) in mouse cortical neurons demonstrated that *MeCP2-S80A* mutation attenuated chromatin association affinity at candidate gene promoters and caused subtle gene expression changes ([@B67]). The mechanistic regulation of histone demethylase function is not clear yet. Two possible regulatory mechanisms are mediated by PTM and association with auxiliary factors ([@B68]). A recent study demonstrated that the H3K4 demethylase Jhd2 is modified by polyubiquitination to control the protein level of Jhd2 through proteasome-mediated degradation ([@B69]). Rosenfeld's group currently reported that phosphorylation on PHF8, a histone H4K20 demethylase, was required for its chromatin dismissal in prophase and was involved in regulating cell cycle progression ([@B70]). The observations in PHF8 and Rph1 strongly support that phosphorylation may be evolutionally linked to the function of histone demethylases responding to diverse cellular signals. Because Rph1 contains multiple putative phosphorylation sites, further studies are required to precisely define the roles of PTMs and putative regulatory factors that are critical for the regulation of histone demethylases.
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